Public health surveillance for hereditary hemochromatosis

Annals of Internal Medicine

Volumn 129, Issue 11, 1998, Pages 980-986

  Wetterhall, Scott F ^a   Cogswell, Mary E ^a   Kowdley, Kris V ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFIDENTIALITY; EPIDEMIOLOGICAL DATA; GOVERNMENT; HEMOCHROMATOSIS; HUMAN; MEDICAL DOCUMENTATION; MONITORING; MORBIDITY; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PRIVACY; PUBLIC HEALTH; REGISTER;

EID: 0032401708     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-11_part_2-199812011-00009     Document Type: Article

References (58)

1. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen. 1996;3:178-84.
2. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 1988;318:1355-62.
3. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13:399-408.
4. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 1985;313:1256-62.
5. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med. 1993;328:1616-20.
6. Haddow JE, Ledue TB. Preventing manifestations of hereditary haemochromatosis through population based screening. J Med Screen. 1994;1:16-21.
7. Thacker SB, Stroup DF. Future directions for comprehensive public health surveillance and health information systems in the United States. Am J Epidemiol. 1994;140:383-97.
8. Teutsch SM. Considerations in planning a surveillance system. In: Teutsch SM, Churchill RE, eds. Principles and Practice of Public Health Surveillance. New York: Oxford Univ Pr; 1994:18-28.
9. Wetterhall SF, Noji EK. Surveillance and epidemiology. In: Noji EK, ed. The Public Health Consequences of Disasters. New York: Oxford Univ Pr; 1997: 37-64.
10. Wetterhall SF, Olson DR, DeStefano F, Stevenson JM, Ford ES, German RR, et al. Trends in diabetes and diabetic complications, 1980-1987. Diabetes Care. 1992;15:960-7.
11. Gable CB. Hemochromatosis and dietary iron supplementation: implications from US mortality, morbidity, and health survey data. J Am Diet Assoc. 1992; 92:208-12.
12. Graves EJ, Gillum BS. National Hospital Discharge Survey. Annual Summary, 1994. Hyattsville, MD: National Center for Health Statistics; 1996.
13. Iron overload disorders among Hispanics - San Diego, California, 1995. MMWR Morb Mortal Wkly Rep. 1996;45:991-3.
14. Looker AC, Johnson CL. Prevalence of elevated serum transferrin saturation in adults in the United States. Ann Intern Med. 1998;129:940-5.
15. McLaren CE, Gordeuk VR, Looker AC, Hasselblad V, Edwards CQ, Griffen LM, et al. Prevalence of heterozygotes for hemochromatosis in the white population of the United States. Blood. 1995;86:2021-7.
16. Looker AC, Gunter EW, Johnson CL. Methods to assess iron status in various NHANES surveys. Nutr Rev. 1995;53:246-54.
17. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. Ann Intern Med. 1998;129:946-53.
18. Andresen EM, Lee JA, Pecoraro RE, Koepsell TD, Hallstrom AP, Siscovick DS. Underreporting of diabetes on death certificates, King County, Washington. Am J Public Health. 1993;83:1021-4.
19. Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, Axelsen EM, et al. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst. 1985;75:81-4.
20. Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 1996;110:1107-19.
21. Kowdley KV, Hassanein T, Kaur S, Farrell FJ, Van Thiel DH, Keeffe EB, et al. Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. Liver Transpl Surg. 1995;1:237-41.
22. Miller M, Hutchins GM. Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease. JAMA. 1994;272:231-3.
23. Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med. 1991;90:445-9.
24. Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol. 1989;42:937-45.
25. May DS, Kelly JJ, Mendlein JM, Garbe PL. Surveillance of major causes of hospitalization among the elderly, 1988. MMWR Morb Mortal Wkly Rep CDC Surveill Summ. 1991;40(SS-1):7-21.
26. Watkins M, Lapham S, Hoy W. Use of a medical center's computerized health care database for notifiable disease surveillance. Am J Public Health. 1991;81:637-9.
27. Thacker SB, Stroup DF, Rothenberg RB. Public health surveillance for chronic conditions: a scientific basis for decisions. Stat Med. 1995;14:629-41.
28. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR, Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat 2. 1992;113:1-35.
29. Stroup NE, Zack MM, Wharton M. Sources of routinely collected data for surveillance. In: Teutsch SM, Churchill RE, eds. Principles and Practice of Public Health Surveillance. New York: Oxford Univ Pr; 1994:31-85.
30. Siegal PZ, Brackbill RM, Frazier EL, Mariolis P, Sanderson LM, Waller MN. Behavioral risk factor surveillance, 1986-1990. MMWR Morb Mortal Wkly Rep CDC Surveill Summ. 1991;40(SS-4):1-23.
31. Woodwell DA. National Ambulatory Medical Care Survey: 1995 Summary. Hyattsville, MD: National Center for Health Statistics; 1997.
32. Schulman J, Edmonds LD, McClearn AB, Jensvold N, Shaw GM. Surveillance for and comparison of birth defect prevalences in two geographic areas - United States, 1983-88. MMWR Morb Mortal Wkly Rep. 1993;42(SS-1):1-7.
33. Austin DF. Cancer registries: a tool in epidemiology. In: Lilienfeld AM, ed. Reviews in Cancer Epidemiology. v. 2. New York: Elsevier; 1983:119-39.
34. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR Morb Mortal Wkly Rep. 1990; 39(RR-13):1-43.
35. Powell LW, Jazwinska E, Halliday JW. Primary iron overload. In. Brock JH, Halliday JW, Pippard MJ, Powell LW, eds. Iron Metabolism in Health and Disease. Philadelphia: WB Saunders; 1994:272-309.
36. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice Guideline Development Task Force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta. 1996;245:139-200.
37. Skikne BS, Cook JD. Screening test for iron overload. Am J Clin Nutr. 1987;46:840-3.
38. Powell LW, George DK, McDonnell SM, Kowdley KV. Diagnosis of hemochromatosis. Ann Intern Med. 1998;129:925-31.
39. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA. 1998;280:172-8.
40. Davis JP, Vergeront JM. The effect of publicity on the reporting of toxic-shock syndrome in Wisconsin. J Infect Dis. 1982;145:449-57.
41. Mast WE, Burrows WM. Erythema chronicum migrans in the United States. JAMA. 1976;236:859-60.
42. Update: trends in AIDS diagnosis and reporting under the expanded surveillance definition for adolescents and adults - United States, 1993. MMWR Morb Mortal Wkly Rep. 1994;43:826-31.
43. Alter MJ, Mares A, Hadler SC, Maynard JE. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol. 1987;125:133-9.
44. Wharton M, Vogt RL. State and local issues in surveillance. In: Teutsch SM, Churchill RE, eds. Principles and Practice of Public Health Surveillance. New York: Oxford Univ Pr; 1994:218-34.
45. Konowitz PM, Petrossian GA, Rose DN. The underreporting of disease and physicians' knowledge of reporting requirements. Public Health Rep. 1984;99:31-5.
46. Meek JI, Roberts CL, Smith EV, Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. Journal of Public Health Management and Practice. 1996;2:61-5.
47. Vogt RL, LaRue D, Klaucke DN, Jillson DA. Comparison of an active and passive surveillance system of primary care providers for hepatitis, measles, rubella, and salmonellosis in Vermont. Am J Public Health. 1983;73:795-7.
48. Thacker SB, Redmond S, Rothenberg RB, Spitz SB, Choi K, White MC. A controlled trial of disease surveillance strategies. Am J Prev Med. 1986;2: 345-50.
49. Alper JS, Geller LN, Barash CI, Billings PR, Laden V, Natowicz MR. Genetic discrimination and screening for hemochromatosis. J Public Health Policy. 1994;15:345-58.
50. Clayton C, Hall P, Mackinnon M. Family screening for genetic haemochromatosis. What is the most effective method of contact? Med J Aust. 1993; 159:614-5.
51. Hudson KL, Rothenberg KH, Andrews LB, Kahn MJ, Collins FS. Genetic discrimination and health insurance: an urgent need for reform. Science. 1995;270:391-3.
52. Rothenberg K, Fuller B, Rothstein M, Duster T, Ellis Kahn MJ, Cunningham R, et al. Genetic information and the workplace: legislative approaches and policy challenges. Science. 1997;275:1755-7.
53. Earley CL, Strong LC. Certificates of confidentiality: a valuable tool for protecting genetic data. Am J Hum Genet. 1995;57:727-31.
54. Clayton EW, Steinberg KK, Khoury MJ, Thomson E, Andrews L, Kahn MJ, et al. Informed consent for genetic research on stored tissue samples. JAMA. 1995;274:1786-92.
55. ASHG report. Statement on storage and use of genetic materials. American College of Medical Genetics Storage of Genetics Materials Committee. Am J Hum Genet. 1995;57:1499-500.
56. ASHG report. Statement on informed consent for genetic research. The American Society of Human Genetics. Am J Hum Genet. 1996;59:471-4.
57. Information Policy Committee, National Information Infrastructure Task Force. Options for promoting privacy on the National Information Infrastructure. Draft for public comment. April 1997. Available at http://www .iitf.nist.gov/ipc/privacy.htm [28 August 1997].
58. Osterholm MT, Birkhead GS, Meriwether RA. Impediments to public health surveillance in the 1990s: the lack of resources and the need for priorities. J Public Health Management Practice. 1996;2:11-5.